Menu
British flagUK American flagUS
CLOSE

Cookie Policy

This website uses cookies to help us give you the best experience when you visit. By using this site you concent to our use of cookies. Click here to read our full Privacy and Cookie Policy.

The ROCA® Test
for Ovarian Cancer

Determines a woman’s risk of having ovarian cancer.

Learn Now

Women coping with ovarian cancer

The Importance of Early Detection

20

women in the UK are diagnosed with ovarian cancer every day.1

5th

most common cause of cancer-related deaths in women in the UK.2

90%

of women survive for at least 5 years if cancer is caught in the earliest stage.3

4%

of women survive 5 years if cancer caught in the latest stage.3

Eligibility

The ROCA Test is intended for women who are between 35 and 85 years old who have tested positive for BRCA1 or BRCA2 gene mutation and who wish to delay risk reducing surgery.

The ROCA Test is available through a number of private clinicians across the UK.  Any woman interested in having survellance using the ROCA Test must have a consultation with a clinician, so that she can understand the latest clinical evidence, and gain an informed view on the benefits and risks of using the ROCA Test.  During the consultation, the clinician will assess your risk of ovarian cancer and your suitability for the test.  Anyone interested should please get in touch with us at rocatest@abcodia.com and we can find a clinician near you.

Learn more about the ROCA Test

Latest News

NHS partners with Abcodia in implementation project for the ROCA Test

UCLH Cancer Collaborative has today launched the first pilot project of an NHS ovarian cancer surveillance service for women who carry a faulty BRCA gene and have chosen not to have their ovaries and fallopian tubes removed.

Read more

All Parliamentary Party Meeting on Ovarian Cancer

To mark World Ovarian Cancer Day on May 8, 2018, the All Parliamentary Party Group (APPG) launched the report of the group’s first ever inquiry ‘Diagnosing ovarian cancer sooner: what more can be done’. The report examines what more needs be done in the prevention, screening, awareness and diagnosis of ovarian cancer. The UKCTOCS and UKFOCSS trials are discussed.

Read more